The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending inductions of Edward Botchwey, Jaydev Desai, Sathya Gourisankar, and Machelle Pardue to its College of Fellows. Each was nominated, reviewed, and elected by peers and members of the College of Fellows for the following:
Edward Botchwey, associate professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory, for outstanding contributions to immunoregulatory biomaterials and national leadership in biomedical engineering.
Jaydev Desai, professor and BME Distinguished Faculty Fellow in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory, for outstanding contributions to medical robotics at the micro, meso, and macro-scale.
Sathya Gourisankar, professor of the practice and director of the Biomedical Innovation and Development Program in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory, for outstanding contribution in medical device product development and transformative leadership in developing a professional master degree program in medical devices.
Machelle Pardue, professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory, for outstanding contributions to understanding and treating blinding diseases, and for extraordinary service to the field.
The College of Fellows is comprised of the top two percent of medical and biological engineers in the country. The most accomplished and distinguished engineering and medical school chairs, research directors, professors, innovators, and successful entrepreneurs, comprise the College of Fellows.
AIMBE Fellows are regularly recognized for their contributions in teaching, research, and innovation. AIMBE Fellows have been awarded the Presidential Medal of Science and the Presidential Medal of Technology and Innovation and many also are members of the National Academy of Engineering, National Academy of Medicine, and the National Academy of Sciences.
A formal induction ceremony will be held during AIMBE’s 2017th annual meeting at the National Academy of Sciences Great Hall in Washington, DC on March 20, 2017. Botchwey, Desai, Gourisankar, and Pardue will be inducted along with new colleagues who make up the AIMBE College of Fellows Class of 2017. For more information about the AIMBE annual meeting, please visit www.aimbe.org.
AIMBE’s mission is to recognize excellence in, and advocate for, the fields of medical and biological engineering in order to advance society. Since 1991, AIMBE‘s College of Fellows has led the way for technological growth and advancement in the fields of medical and biological engineering. Fellows have helped revolutionize medicine and related fields in order to enhance and extend the lives of people all over the world. They have also successfully advocated for public policies that have enabled researchers and business-makers to further the interests of engineers, teachers, scientists, clinical practitioners, and ultimately, patients.
For questions regarding the College of Fellows and AIMBE, please contact Jason R. Hibner, AIMBE Director of Member Services and Operations at jhibner@aimbe.org, or call the AIMBE office at 202-496-9660.
###
Media Contact
Walter Rich
Keywords
Latest BME News
Researchers demonstrate stem cell treatment without chemotherapy and painful bone marrow procedure
BME researchers explore the critical role of mechanical force in rare genetic disorder
Researchers develop spatial transcriptomics toolkit that provides new insights into the molecular processes of life
Air Detectives take top prize to give department three straight victories in Expo competition
Coulter BME community gathers at the Fabulous Fox to celebrate anniversary of unique public-private partnership
Coskun pioneering new research area and building a company around iseqPLA technology
BME undergraduate student and competitive skater Sierra Venetta has found success on and off the ice
BME researcher Ankur Singh using new technology to uncover weakened response in cancer patients